MedPage Today) — SAN DIEGO — Treatment with abaloparatide (Tymlos) was safe and effective for men with osteoporosis, according to the phase III ATOM trial.
Compared with a 1.2% increase with placebo, men randomized to receive 80 μg of…
Read More
MedPage Today) — SAN DIEGO — Treatment with abaloparatide (Tymlos) was safe and effective for men with osteoporosis, according to the phase III ATOM trial.
Compared with a 1.2% increase with placebo, men randomized to receive 80 μg of…
Read More